{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:38:00Z","timestamp":1781591880690,"version":"3.54.5"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00284-022-03003-3","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T20:37:13Z","timestamp":1662410233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunology to Immunotherapeutics of SARS-CoV-2: Identification of Immunogenic Epitopes for Vaccine Development"],"prefix":"10.1007","volume":"79","author":[{"given":"Apoorva","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3529-4702","authenticated-orcid":false,"given":"Swati","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"3003_CR1","unstructured":"Weekly epidemiological update on COVID-19 - 6 July 2022 (n.d.) https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19---6-july-2022. Accessed 8 July 2022"},{"key":"3003_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003303","author":"JR Greenland","year":"2020","unstructured":"Greenland JR, Michelow MD, Wang L, London MJ (2020) COVID-19 infection: implications for perioperative and critical care physicians. Anesthesiology. https:\/\/doi.org\/10.1097\/ALN.0000000000003303","journal-title":"Anesthesiology"},{"key":"3003_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jmv.25685","volume":"92","author":"G Li","year":"2020","unstructured":"Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P et al (2020) Coronavirus infections and immune responses. J Med Virol 92:424\u2013432. https:\/\/doi.org\/10.1002\/jmv.25685","journal-title":"J Med Virol"},{"key":"3003_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP (2020) The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 20:363\u2013374. https:\/\/doi.org\/10.1038\/s41577-020-0311-8","journal-title":"Nat Rev Immunol"},{"key":"3003_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"3003_CR6","unstructured":"Symptoms of Coronavirus | CDC n.d."},{"key":"3003_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507\u2013513. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7","journal-title":"Lancet"},{"key":"3003_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"J Cui","year":"2019","unstructured":"Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17:181\u2013192. https:\/\/doi.org\/10.1038\/s41579-018-0118-9","journal-title":"Nat Rev Microbiol"},{"key":"3003_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727\u2013733. https:\/\/doi.org\/10.1056\/NEJMoa2001017","journal-title":"N Engl J Med"},{"key":"3003_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/J.JVIROMET.2020.114032","volume":"289","author":"Z Chen","year":"2021","unstructured":"Chen Z, Boon SS, Wang MH, Chan RWY, Chan PKS (2021) Genomic and evolutionary comparison between SARS-CoV-2 and other human coronaviruses. J Virol Methods 289:114032. https:\/\/doi.org\/10.1016\/J.JVIROMET.2020.114032","journal-title":"J Virol Methods"},{"key":"3003_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.552909","author":"Z Abdelrahman","year":"2020","unstructured":"Abdelrahman Z, Li M, Wang X (2020) Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza A respiratory viruses. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.552909","journal-title":"Front Immunol"},{"key":"3003_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395:565\u2013574. https:\/\/doi.org\/10.1016\/S0140-6736(20)30251-8","journal-title":"Lancet"},{"key":"3003_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270\u2013273. https:\/\/doi.org\/10.1038\/s41586-020-2012-7","journal-title":"Nature"},{"key":"3003_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15562-9","volume":"11","author":"X Ou","year":"2020","unstructured":"Ou X, Liu Y, Lei X, Li P, Mi D, Ren L et al (2020) Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 11:1\u201312. https:\/\/doi.org\/10.1038\/s41467-020-15562-9","journal-title":"Nat Commun"},{"key":"3003_CR15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","volume":"24","author":"S Su","year":"2016","unstructured":"Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J et al (2016) Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 24:490\u2013502. https:\/\/doi.org\/10.1016\/j.tim.2016.03.003","journal-title":"Trends Microbiol"},{"key":"3003_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/v12030254","volume":"12","author":"SF Ahmed","year":"2020","unstructured":"Ahmed SF, Quadeer AA, McKay MR (2020) Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses 12:254. https:\/\/doi.org\/10.3390\/v12030254","journal-title":"Viruses"},{"key":"3003_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","volume-title":"Coronaviruses: an overview of their replication and pathogenesis. Coronaviruses methods protoc.","author":"AR Fehr","year":"2015","unstructured":"Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis. Coronaviruses methods protoc., vol 1282. Springer, New York, pp 1\u201323. https:\/\/doi.org\/10.1007\/978-1-4939-2438-7_1"},{"key":"3003_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/S12038-021-00145-7","author":"S Srivastava","year":"2021","unstructured":"Srivastava S, Banu S, Singh P, Sowpati DT, Mishra RK (2021) SARS-CoV-2 genomics: an Indian perspective on sequencing viral variants. J Biosci. https:\/\/doi.org\/10.1007\/S12038-021-00145-7","journal-title":"J Biosci"},{"key":"3003_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-00609-8","volume":"11","author":"S Jain","year":"2021","unstructured":"Jain S, Xiao X, Bogdan P, Bruck J (2021) Generator based approach to analyze mutations in genomic datasets. Sci Rep 11:1\u201312. https:\/\/doi.org\/10.1038\/s41598-021-00609-8","journal-title":"Sci Rep"},{"key":"3003_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.26.222117","author":"S Jain","year":"2020","unstructured":"Jain S, Xiao X, Bogdan P, Bruck J (2020) Predicting the emergence of SARS-CoV-2 clades. BioRxiv. https:\/\/doi.org\/10.1101\/2020.07.26.222117","journal-title":"BioRxiv"},{"key":"3003_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0264198","volume":"17","author":"JK Miller","year":"2022","unstructured":"Miller JK, Elenberg K, Dubrawski A (2022) Forecasting emergence of COVID-19 variants of concern. PLoS ONE 17:e0264198. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0264198","journal-title":"PLoS ONE"},{"key":"3003_CR22","unstructured":"Sungnak W, Huang N, B\u00e9cavin C, Berg M, HCA Lung Biological Network (2020) SARS-CoV-2 entry genes are most highly expressed in nasal goblet and ciliated cells within human airways. ArXiv"},{"key":"3003_CR23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631\u2013637. https:\/\/doi.org\/10.1002\/path.1570","journal-title":"J Pathol"},{"key":"3003_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1473-3099(09)70069-6","volume":"9","author":"J Lessler","year":"2009","unstructured":"Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA (2009) Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 9:291\u2013300. https:\/\/doi.org\/10.1016\/S1473-3099(09)70069-6","journal-title":"Lancet Infect Dis"},{"key":"3003_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","volume":"14","author":"E De Wit","year":"2016","unstructured":"De Wit E, Van Doremalen N, Falzarano D, Munster VJ (2016) SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 14:523\u2013534. https:\/\/doi.org\/10.1038\/nrmicro.2016.81","journal-title":"Nat Rev Microbiol"},{"key":"3003_CR26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA et al (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450\u2013454. https:\/\/doi.org\/10.1038\/nature02145","journal-title":"Nature"},{"key":"3003_CR27","doi-asserted-by":"publisher","first-page":"15748","DOI":"10.1073\/pnas.0403812101","volume":"101","author":"SA Jeffers","year":"2004","unstructured":"Jeffers SA, Tusell SM, Gillim-Ross L, Hemmila EM, Achenbach JE, Babcock GJ et al (2004) CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci USA 101:15748\u201315753. https:\/\/doi.org\/10.1073\/pnas.0403812101","journal-title":"Proc Natl Acad Sci USA"},{"key":"3003_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG et al (2020) A new coronavirus associated with human respiratory disease in China. Nature 579:265\u2013269. https:\/\/doi.org\/10.1038\/s41586-020-2008-3","journal-title":"Nature"},{"key":"3003_CR29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","volume":"495","author":"VS Raj","year":"2013","unstructured":"Raj VS, Mou H, Smits SL, Dekkers DHW, M\u00fcller MA, Dijkman R et al (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495:251\u2013254. https:\/\/doi.org\/10.1038\/nature12005","journal-title":"Nature"},{"key":"3003_CR30","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1073\/pnas.0306446101","volume":"101","author":"G Simmons","year":"2004","unstructured":"Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P (2004) Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci USA 101:4240\u20134245. https:\/\/doi.org\/10.1073\/pnas.0306446101","journal-title":"Proc Natl Acad Sci USA"},{"key":"3003_CR31","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1073\/pnas.0809524106","volume":"106","author":"S Belouzard","year":"2009","unstructured":"Belouzard S, Chu VC, Whittaker GR (2009) Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci USA 106:5871\u20135876. https:\/\/doi.org\/10.1073\/pnas.0809524106","journal-title":"Proc Natl Acad Sci USA"},{"key":"3003_CR32","doi-asserted-by":"publisher","first-page":"15214","DOI":"10.1073\/pnas.1407087111","volume":"111","author":"JK Mille","year":"2014","unstructured":"Mille JK, Whittaker GR (2014) Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc Natl Acad Sci USA 111:15214\u201315219. https:\/\/doi.org\/10.1073\/pnas.1407087111","journal-title":"Proc Natl Acad Sci USA"},{"key":"3003_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, M\u00fc MA, Drosten C, P\u00f6 S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271-280.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"3003_CR34","doi-asserted-by":"publisher","first-page":"6150","DOI":"10.1128\/jvi.03372-12","volume":"87","author":"S Bertram","year":"2013","unstructured":"Bertram S, Dijkman R, Habjan M, Heurich A, Gierer S, Glowacka I et al (2013) TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. J Virol 87:6150\u20136160. https:\/\/doi.org\/10.1128\/jvi.03372-12","journal-title":"J Virol"},{"key":"3003_CR35","doi-asserted-by":"publisher","first-page":"12262","DOI":"10.1073\/pnas.1608147113","volume":"113","author":"JE Park","year":"2016","unstructured":"Park JE, Li K, Barlan A, Fehr AR, Perlman S, McCray PB et al (2016) Proteolytic processing of middle east respiratory syndrome coronavirus spikes expands virus tropism. Proc Natl Acad Sci USA 113:12262\u201312267. https:\/\/doi.org\/10.1073\/pnas.1608147113","journal-title":"Proc Natl Acad Sci USA"},{"key":"3003_CR36","doi-asserted-by":"publisher","first-page":"5502","DOI":"10.1128\/jvi.00128-13","volume":"87","author":"S Gierer","year":"2013","unstructured":"Gierer S, Bertram S, Kaup F, Wrensch F, Heurich A, Kramer-Kuhl A et al (2013) The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol 87:5502\u20135511. https:\/\/doi.org\/10.1128\/jvi.00128-13","journal-title":"J Virol"},{"key":"3003_CR37","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A et al (2020) Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA 117:11727\u201311734. https:\/\/doi.org\/10.1073\/pnas.2003138117","journal-title":"Proc Natl Acad Sci USA"},{"key":"3003_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108448","volume":"215","author":"S Felsenstein","year":"2020","unstructured":"Felsenstein S, Herbert JA, McNamara PS, Hedrich CM (2020) COVID-19: immunology and treatment options. Clin Immunol 215:108448. https:\/\/doi.org\/10.1016\/j.clim.2020.108448","journal-title":"Clin Immunol"},{"key":"3003_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.virusres.2007.03.015","volume":"133","author":"M Frieman","year":"2008","unstructured":"Frieman M, Heise M, Baric R (2008) SARS coronavirus and innate immunity. Virus Res 133:101\u2013112. https:\/\/doi.org\/10.1016\/j.virusres.2007.03.015","journal-title":"Virus Res"},{"key":"3003_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0165-2478(02)00228-6","volume":"85","author":"S Akira","year":"2003","unstructured":"Akira S, Hemmi H (2003) Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85:85\u201395. https:\/\/doi.org\/10.1016\/S0165-2478(02)00228-6","journal-title":"Immunol Lett"},{"key":"3003_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00281-004-0180-4","volume":"26","author":"T Ito","year":"2005","unstructured":"Ito T, Wang YH, Liu YJ (2005) Plasmacytoid dendritic cell precursors\/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9. Springer Semin Immunopathol 26:221\u2013229. https:\/\/doi.org\/10.1007\/s00281-004-0180-4","journal-title":"Springer Semin Immunopathol"},{"key":"3003_CR42","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","volume":"52","author":"N Vabret","year":"2020","unstructured":"Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M et al (2020) Immunology of COVID-19: current state of the science. Immunity 52:910\u2013941. https:\/\/doi.org\/10.1016\/j.immuni.2020.05.002","journal-title":"Immunity"},{"key":"3003_CR43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/bs.aivir.2016.08.006","volume":"96","author":"E Kindler","year":"2016","unstructured":"Kindler E, Thiel V, Weber F (2016) Interaction of SARS and MERS coronaviruses with the antiviral interferon response. Adv Virus Res 96:219\u2013243. https:\/\/doi.org\/10.1016\/bs.aivir.2016.08.006","journal-title":"Adv Virus Res"},{"key":"3003_CR44","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1126\/science.1093620","volume":"303","author":"F Heil","year":"2004","unstructured":"Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S et al (2004) Species-specific recognition of single-stranded RNA via Till-like receptor 7 and 8. Science 303:1526\u20131529. https:\/\/doi.org\/10.1126\/science.1093620","journal-title":"Science"},{"key":"3003_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1600-0463.2009.02456.x","volume":"117","author":"SB Rasmussen","year":"2009","unstructured":"Rasmussen SB, Reinert LS, Paludan SR (2009) Innate recognition of intracellular pathogens: detection and activation of the first line of defense. APMIS 117:323\u2013337. https:\/\/doi.org\/10.1111\/j.1600-0463.2009.02456.x","journal-title":"APMIS"},{"key":"3003_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00342","author":"S Reikine","year":"2014","unstructured":"Reikine S, Nguyen JB, Modis Y (2014) Pattern recognition and signaling mechanisms of RIG-I and MDA5. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2014.00342","journal-title":"Front Immunol"},{"key":"3003_CR47","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.4049\/jimmunol.1303196","volume":"193","author":"C-S Shi","year":"2014","unstructured":"Shi C-S, Qi H-Y, Boularan C, Huang N-N, Abu-Asab M, Shelhamer JH et al (2014) SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS\/TRAF3\/TRAF6 signalosome. J Immunol 193:3080\u20133089. https:\/\/doi.org\/10.4049\/jimmunol.1303196","journal-title":"J Immunol"},{"key":"3003_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006720","volume":"13","author":"R Fang","year":"2017","unstructured":"Fang R, Jiang Q, Zhou X, Wang C, Guan Y, Tao J et al (2017) MAVS activates TBK1 and IKK\u03b5 through TRAFs in NEMO dependent and independent manner. PLoS Pathog 13:e1006720. https:\/\/doi.org\/10.1371\/journal.ppat.1006720","journal-title":"PLoS Pathog"},{"key":"3003_CR49","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00785.001","author":"S Liu","year":"2013","unstructured":"Liu S, Chen J, Cai X, Wu J, Chen X, Wu YT et al (2013) MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. Elife. https:\/\/doi.org\/10.7554\/eLife.00785.001","journal-title":"Elife"},{"key":"3003_CR50","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.immuni.2011.05.003","volume":"34","author":"YM Loo","year":"2011","unstructured":"Loo YM, Gale M (2011) Immune signaling by RIG-I-like receptors. Immunity 34:680\u2013692. https:\/\/doi.org\/10.1016\/j.immuni.2011.05.003","journal-title":"Immunity"},{"key":"3003_CR51","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805\u2013820. https:\/\/doi.org\/10.1016\/j.cell.2010.01.022","journal-title":"Cell"},{"key":"3003_CR52","doi-asserted-by":"publisher","DOI":"10.12932\/AP-200220-0772","author":"E Prompetchara","year":"2020","unstructured":"Prompetchara E, Ketloy C, Palaga T (2020) Allergy and immunology immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. https:\/\/doi.org\/10.12932\/AP-200220-0772","journal-title":"Asian Pac J Allergy Immunol"},{"key":"3003_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","volume":"19","author":"R Channappanavar","year":"2016","unstructured":"Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK et al (2016) Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe 19:181\u2013193. https:\/\/doi.org\/10.1016\/j.chom.2016.01.007","journal-title":"Cell Host Microbe"},{"key":"3003_CR54","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1172\/JCI126363","volume":"129","author":"R Channappanavar","year":"2019","unstructured":"Channappanavar R, Fehr AR, Zheng J, Wohlford-Lenane C, Abrahante JE, Mack M et al (2019) IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Investig 129:3625\u20133639. https:\/\/doi.org\/10.1172\/JCI126363","journal-title":"J Clin Investig"},{"key":"3003_CR55","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.immuni.2010.10.008","volume":"33","author":"F Sallusto","year":"2010","unstructured":"Sallusto F, Lanzavecchia A, Araki K, Ahmed R (2010) From vaccines to memory and back. Immunity 33:451\u2013463. https:\/\/doi.org\/10.1016\/j.immuni.2010.10.008","journal-title":"Immunity"},{"key":"3003_CR56","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.12.20021386","author":"X Guo","year":"2020","unstructured":"Guo X, Guo Z, Duan C, Chen Z, Wang G, Lu Y et al (2020) Long-term persistence of IgG antibodies in SARS-CoV infected healthcare workers. MedRxiv. https:\/\/doi.org\/10.1101\/2020.02.12.20021386","journal-title":"MedRxiv"},{"key":"3003_CR57","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.4049\/jimmunol.181.8.5490","volume":"181","author":"CK Li","year":"2008","unstructured":"Li CK, Wu H, Yan H, Ma S, Wang L, Zhang M et al (2008) T cell responses to whole SARS coronavirus in humans. J Immunol 181:5490\u20135500. https:\/\/doi.org\/10.4049\/jimmunol.181.8.5490","journal-title":"J Immunol"},{"key":"3003_CR58","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12026-014-8534-z","volume":"59","author":"R Channappanavar","year":"2014","unstructured":"Channappanavar R, Zhao J, Perlman S (2014) T cell-mediated immune response to respiratory coronaviruses. Immunol Res 59:118\u2013128. https:\/\/doi.org\/10.1007\/s12026-014-8534-z","journal-title":"Immunol Res"},{"key":"3003_CR59","doi-asserted-by":"publisher","first-page":"8670","DOI":"10.1073\/pnas.0402644101","volume":"101","author":"GT Belz","year":"2004","unstructured":"Belz GT, Smith CM, Kleinert L, Reading P, Brooks A, Shortman K et al (2004) Distinct migrating and nonmigrating dendritic cell population are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc Natl Acad Sci USA 101:8670\u20138675. https:\/\/doi.org\/10.1073\/pnas.0402644101","journal-title":"Proc Natl Acad Sci USA"},{"key":"3003_CR60","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.4049\/jimmunol.165.3.1182","volume":"165","author":"M Larsson","year":"2000","unstructured":"Larsson M, Messmer D, Somersan S, Fonteneau J-F, Donahoe SM, Lee M et al (2000) Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8 + T cells. J Immunol 165:1182\u20131190. https:\/\/doi.org\/10.4049\/jimmunol.165.3.1182","journal-title":"J Immunol"},{"key":"3003_CR61","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ni762","volume":"3","author":"CC Norbury","year":"2002","unstructured":"Norbury CC, Malide D, Gibbs JS, Bennink JR, Yewdell JW (2002) Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat Immunol 3:265\u2013271. https:\/\/doi.org\/10.1038\/ni762","journal-title":"Nat Immunol"},{"key":"3003_CR62","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.humimm.2009.05.006","volume":"70","author":"N Keicho","year":"2009","unstructured":"Keicho N, Itoyama S, Kashiwase K, Phi NC, Long HT, Ha LD et al (2009) Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population. Hum Immunol 70:527\u2013531. https:\/\/doi.org\/10.1016\/j.humimm.2009.05.006","journal-title":"Hum Immunol"},{"key":"3003_CR63","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1089\/vim.2011.0024","volume":"24","author":"SF Wang","year":"2011","unstructured":"Wang SF, Chen KH, Chen M, Li WY, Chen YJ, Tsao CH et al (2011) Human-leukocyte antigen class i Cw 1502 and class II DR 0301 genotypes are associated with resistance to severe acute respiratory syndrome (SARS) infection. Viral Immunol 24:421\u2013426. https:\/\/doi.org\/10.1089\/vim.2011.0024","journal-title":"Viral Immunol"},{"key":"3003_CR64","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1128\/jvi.78.11.5535-5545.2004","volume":"78","author":"EJ Wherry","year":"2004","unstructured":"Wherry EJ, Ahmed R (2004) Memory CD8 T-cell differentiation during viral infection. J Virol 78:5535\u20135545. https:\/\/doi.org\/10.1128\/jvi.78.11.5535-5545.2004","journal-title":"J Virol"},{"key":"3003_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2009.11.021","volume":"50","author":"B Saha","year":"2010","unstructured":"Saha B, Jyothi Prasanna S, Chandrasekar B, Nandi D (2010) Gene modulation and immunoregulatory roles of Interferon\u03b3. Cytokine 50:1\u201314. https:\/\/doi.org\/10.1016\/j.cyto.2009.11.021","journal-title":"Cytokine"},{"key":"3003_CR66","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1084\/jem.189.2.423","volume":"189","author":"A Cerwenka","year":"1999","unstructured":"Cerwenka A, Morgan TM, Harmsen AG, Dutton RW (1999) Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J Exp Med 189:423\u2013434. https:\/\/doi.org\/10.1084\/jem.189.2.423","journal-title":"J Exp Med"},{"key":"3003_CR67","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.4049\/jimmunol.163.10.5535","volume":"163","author":"A Cerwenka","year":"1999","unstructured":"Cerwenka A, Morgan TM, Dutton RW (1999) Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J Immunol 163:5535\u20135543","journal-title":"J Immunol"},{"key":"3003_CR68","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-4615-0757-4_15","volume":"512","author":"SL Swain","year":"2002","unstructured":"Swain SL, Agrewala JN, Brown DM, Rom\u00e1n E (2002) Regulation of memory CD4 T cells: generation, localization and persistence. Adv Exp Med Biol 512:113\u2013120. https:\/\/doi.org\/10.1007\/978-1-4615-0757-4_15","journal-title":"Adv Exp Med Biol"},{"key":"3003_CR69","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1084\/jem.20021052","volume":"196","author":"E Rom\u00e1n","year":"2002","unstructured":"Rom\u00e1n E, Miller E, Harmsen A, Wiley J, Von Andrian UH, Huston G et al (2002) CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J Exp Med 196:957\u2013968. https:\/\/doi.org\/10.1084\/jem.20021052","journal-title":"J Exp Med"},{"key":"3003_CR70","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nm1080","volume":"10","author":"E Traggiai","year":"2004","unstructured":"Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR et al (2004) An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 10:871\u2013875. https:\/\/doi.org\/10.1038\/nm1080","journal-title":"Nat Med"},{"key":"3003_CR71","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.2215\/CJN.06230614","volume":"10","author":"DR Mathern","year":"2015","unstructured":"Mathern DR, Heeger PS (2015) Molecules great and small: the complement system. Clin J Am Soc Nephrol 10:1636\u20131650. https:\/\/doi.org\/10.2215\/CJN.06230614","journal-title":"Clin J Am Soc Nephrol"},{"key":"3003_CR72","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1080\/22221751.2020.1773324","volume":"9","author":"X Liu","year":"2020","unstructured":"Liu X, Wang J, Xu X, Liao G, Chen Y, Hu C-H (2020) Patterns of IgG and IgM antibody response in COVID-19 patients. Emerg Microbes Infect 9:1269\u20131274. https:\/\/doi.org\/10.1080\/22221751.2020.1773324","journal-title":"Emerg Microbes Infect"},{"key":"3003_CR73","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.7150\/ijbs.45134","volume":"16","author":"Y Yi","year":"2020","unstructured":"Yi Y, Lagniton PNP, Ye S, Li E, Xu RH (2020) COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci 16:1753\u20131766. https:\/\/doi.org\/10.7150\/ijbs.45134","journal-title":"Int J Biol Sci"},{"key":"3003_CR74","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.25.20025643","volume-title":"Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19 pneumonia","author":"J Gong","year":"2020","unstructured":"Gong J, Dong H, Xia SQ, Huang YZ, Wang D, Zhao Y et al (2020) Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19 pneumonia. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. https:\/\/doi.org\/10.1101\/2020.02.25.20025643"},{"key":"3003_CR75","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","volume":"117","author":"X Xu","year":"2020","unstructured":"Xu X, Han M, Li T, Sun W, Wang D, Fu B et al (2020) Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci USA 117:10970\u201310975. https:\/\/doi.org\/10.1073\/pnas.2005615117","journal-title":"Proc Natl Acad Sci USA"},{"key":"3003_CR76","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.abb8925","volume":"368","author":"JB Moore","year":"2020","unstructured":"Moore JB, June CH (2020) Cytokine release syndrome in severe COVID-19. Science 368:473\u2013474. https:\/\/doi.org\/10.1126\/science.abb8925","journal-title":"Science"},{"key":"3003_CR77","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.10.20021832","volume-title":"Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)","author":"S Wan","year":"2020","unstructured":"Wan S, Yi Q, Fan S, Lv J, Zhang X, Guo L et al (2020) Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). Cold Spring Harbor Laboratory Press, Cold Spring Harbor. https:\/\/doi.org\/10.1101\/2020.02.10.20021832"},{"key":"3003_CR78","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.27.20045427","author":"Z Feng","year":"2020","unstructured":"Feng Z, Diao B, Wang R, Wang G, Wang C et al (2020) The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes. MedRxiv. https:\/\/doi.org\/10.1101\/2020.03.27.20045427","journal-title":"MedRxiv"},{"key":"3003_CR79","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"B Diao","year":"2020","unstructured":"Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L et al (2020) Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 11:827. https:\/\/doi.org\/10.3389\/fimmu.2020.00827","journal-title":"Front Immunol"},{"key":"3003_CR80","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ijid.2020.03.003","volume":"93","author":"D Chen","year":"2020","unstructured":"Chen D, Xu W, Lei Z, Huang Z, Liu J, Gao Z et al (2020) Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report. Int J Infect Dis 93:297\u2013299. https:\/\/doi.org\/10.1016\/j.ijid.2020.03.003","journal-title":"Int J Infect Dis"},{"key":"3003_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-0191-1","volume":"5","author":"M Catanzaro","year":"2020","unstructured":"Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S, Lanni C (2020) Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct Target Ther 5:1\u201310. https:\/\/doi.org\/10.1038\/s41392-020-0191-1","journal-title":"Signal Transduct Target Ther"},{"key":"3003_CR82","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","volume":"17","author":"M Zheng","year":"2020","unstructured":"Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D et al (2020) Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol 17:533\u2013535. https:\/\/doi.org\/10.1038\/s41423-020-0402-2","journal-title":"Cell Mol Immunol"},{"key":"3003_CR83","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.23.20040675","volume-title":"Analysis of adaptive immune cell populations and phenotypes in the patients infected by SARS-CoV-2","author":"X Yang","year":"2020","unstructured":"Yang X, Dai T, Zhou X, Qian H, Guo R, Lei L et al (2020) Analysis of adaptive immune cell populations and phenotypes in the patients infected by SARS-CoV-2. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. https:\/\/doi.org\/10.1101\/2020.03.23.20040675"},{"key":"3003_CR84","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","volume":"26","author":"I Thevarajan","year":"2020","unstructured":"Thevarajan I, Nguyen THO, Koutsakos M, Druce J, Caly L, van de Sandt CE et al (2020) Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med 26:453\u2013455. https:\/\/doi.org\/10.1038\/s41591-020-0819-2","journal-title":"Nat Med"},{"key":"3003_CR85","doi-asserted-by":"publisher","first-page":"9029","DOI":"10.1128\/jvi.01331-15","volume":"89","author":"L Cui","year":"2015","unstructured":"Cui L, Wang H, Ji Y, Yang J, Xu S, Huang X et al (2015) The nucleocapsid protein of coronaviruses acts as a viral suppressor of RNA silencing in mammalian cells. J Virol 89:9029\u20139043. https:\/\/doi.org\/10.1128\/jvi.01331-15","journal-title":"J Virol"},{"key":"3003_CR86","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11262-010-0544-x","volume":"42","author":"X Lu","year":"2011","unstructured":"Lu X, Pan J, Tao J, Guo D (2011) SARS-CoV nucleocapsid protein antagonizes IFN-\u03b2 response by targeting initial step of IFN-\u03b2 induction pathway, and its C-terminal region is critical for the antagonism. Virus Genes 42:37\u201345. https:\/\/doi.org\/10.1007\/s11262-010-0544-x","journal-title":"Virus Genes"},{"key":"3003_CR87","doi-asserted-by":"publisher","first-page":"5927","DOI":"10.1128\/jvi.02501-05","volume":"80","author":"EJ Snijder","year":"2006","unstructured":"Snijder EJ, van der Meer Y, Zevenhoven-Dobbe J, Onderwater JJM, van der Meulen J, Koerten HK et al (2006) Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J Virol 80:5927\u20135940. https:\/\/doi.org\/10.1128\/jvi.02501-05","journal-title":"J Virol"},{"key":"3003_CR88","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1128\/jvi.01782-06","volume":"81","author":"SA Kopecky-Bromberg","year":"2007","unstructured":"Kopecky-Bromberg SA, Mart\u00ednez-Sobrido L, Frieman M, Baric RA, Palese P (2007) Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol 81:548\u2013557. https:\/\/doi.org\/10.1128\/jvi.01782-06","journal-title":"J Virol"},{"key":"3003_CR89","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1128\/jvi.00367-09","volume":"83","author":"EC Freundt","year":"2009","unstructured":"Freundt EC, Yu L, Park E, Lenardo MJ, Xu X-N (2009) Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein. J Virol 83:6631\u20136640. https:\/\/doi.org\/10.1128\/jvi.00367-09","journal-title":"J Virol"},{"key":"3003_CR90","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s13238-013-3096-8","volume":"4","author":"Y Yang","year":"2013","unstructured":"Yang Y, Zhang L, Geng H, Deng Y, Huang B, Guo Y et al (2013) The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell 4:951\u2013961. https:\/\/doi.org\/10.1007\/s13238-013-3096-8","journal-title":"Protein Cell"},{"key":"3003_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/srep17554","author":"Y Yang","year":"2015","unstructured":"Yang Y, Ye F, Zhu N, Wang W, Deng Y, Zhao Z et al (2015) Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets. Sci Rep. https:\/\/doi.org\/10.1038\/srep17554","journal-title":"Sci Rep"},{"key":"3003_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1000863","volume":"6","author":"M Bouvet","year":"2010","unstructured":"Bouvet M, Debarnot C, Imbert I, Selisko B, Snijder EJ, Canard B et al (2010) In vitro reconstitution of sars-coronavirus mRNA cap methylation. PLoS Pathog 6:1\u201313. https:\/\/doi.org\/10.1371\/journal.ppat.1000863","journal-title":"PLoS Pathog"},{"key":"3003_CR93","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/vim.1989.2.143","volume":"2","author":"MG Rossmann","year":"1989","unstructured":"Rossmann MG (1989) The canyon hypothesis. Viral Immunol 2:143\u2013161. https:\/\/doi.org\/10.1089\/vim.1989.2.143","journal-title":"Viral Immunol"},{"key":"3003_CR94","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nature01188","volume":"420","author":"PD Kwong","year":"2002","unstructured":"Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, Majeed S et al (2002) HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420:678\u2013682. https:\/\/doi.org\/10.1038\/nature01188","journal-title":"Nature"},{"key":"3003_CR95","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tim.2007.03.003","volume":"15","author":"DJ Vigerust","year":"2007","unstructured":"Vigerust DJ, Shepherd VL (2007) Virus glycosylation: role in virulence and immune interactions. Trends Microbiol 15:211\u2013218. https:\/\/doi.org\/10.1016\/j.tim.2007.03.003","journal-title":"Trends Microbiol"},{"key":"3003_CR96","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.it.2006.09.004","volume":"27","author":"M Zanetti","year":"2006","unstructured":"Zanetti M, Franchini G (2006) T cell memory and protective immunity by vaccination: is more better? Trends Immunol 27:511\u2013517. https:\/\/doi.org\/10.1016\/j.it.2006.09.004","journal-title":"Trends Immunol"},{"key":"3003_CR97","doi-asserted-by":"publisher","unstructured":"Mar\u00eda RR, Arturo CJ, Alicia JA, Paulina MG, Gerardo AO (2017) The impact of bioinformatics on vaccine design and development. In: Vaccines. InTech, London. https:\/\/doi.org\/10.5772\/intechopen.69273","DOI":"10.5772\/intechopen.69273"},{"key":"3003_CR98","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1039\/D1RA06532G","volume":"12","author":"MO Rafi","year":"2022","unstructured":"Rafi MO, Al-Khafaji K, Sarker MT, Taskin-Tok T, Rana AS, Rahman MS (2022) Design of a multi-epitope vaccine against SARS-CoV-2: immunoinformatic and computational methods. RSC Adv 12:4288\u20134310. https:\/\/doi.org\/10.1039\/D1RA06532G","journal-title":"RSC Adv"},{"key":"3003_CR99","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1792347","author":"A Samad","year":"2020","unstructured":"Samad A, Ahammad F, Nain Z, Alam R, Imon RR, Hasan M et al (2020) Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformaticsapproach. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1792347","journal-title":"J Biomol Struct Dyn"},{"key":"3003_CR100","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.chom.2020.03.002","volume":"27","author":"A Grifoni","year":"2020","unstructured":"Grifoni A, Sidney J, Zhang Y, Scheuermann RH, Peters B, Sette A (2020) A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2. Cell Host Microbe 27:671-680.e2. https:\/\/doi.org\/10.1016\/j.chom.2020.03.002","journal-title":"Cell Host Microbe"},{"key":"3003_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.015","author":"A Grifoni","year":"2020","unstructured":"Grifoni A, Weiskopf D, Ramirez SI, Smith DM, Crotty S, Sette A (2020) Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. https:\/\/doi.org\/10.1016\/j.cell.2020.05.015","journal-title":"Cell"},{"key":"3003_CR102","doi-asserted-by":"publisher","first-page":"145","DOI":"10.12688\/f1000research.22507.2","volume":"9","author":"CH Lee","year":"2020","unstructured":"Lee CH, Koohy H (2020) In silico identification of vaccine targets for 2019-nCoV. F1000Research 9:145. https:\/\/doi.org\/10.12688\/f1000research.22507.2","journal-title":"F1000Research"},{"key":"3003_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2020.05.012","author":"YT Wang","year":"2020","unstructured":"Wang YT, Landeras-Bueno S, Hsieh LE, Terada Y, Kim K, Ley K et al (2020) Spiking pandemic potential: structural and immunological aspects of SARS-CoV-2. Trends Microbiol. https:\/\/doi.org\/10.1016\/j.tim.2020.05.012","journal-title":"Trends Microbiol"},{"key":"3003_CR104","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s13337-020-00571-5","volume":"31","author":"S Kumar","year":"2020","unstructured":"Kumar S, Maurya VK, Prasad AK, Bhatt MLB, Saxena SK (2020) Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). VirusDisease 31:13\u201321. https:\/\/doi.org\/10.1007\/s13337-020-00571-5","journal-title":"VirusDisease"},{"key":"3003_CR105","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2683286","author":"MI Abdelmageed","year":"2020","unstructured":"Abdelmageed MI, Abdelmoneim AH, Mustafa MI, Elfadol NM, Murshed NS, Shantier SW et al (2020) Design of a multiepitope-based peptide vaccine against the e protein of human COVID-19: an immunoinformatics approach. Biomed Res Int. https:\/\/doi.org\/10.1155\/2020\/2683286","journal-title":"Biomed Res Int"},{"key":"3003_CR106","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1770127","author":"KA Peele","year":"2020","unstructured":"Peele KA, Srihansa T, Krupanidhi S, Sai AV, Venkateswarulu TC (2020) Design of multi-epitope vaccine candidate against SARS-CoV-2: a in-silico study. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1770127","journal-title":"J Biomol Struct Dyn"},{"key":"3003_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104236","volume":"145","author":"P Kalita","year":"2020","unstructured":"Kalita P, Padhi AK, Zhang KYJ, Tripathi T (2020) Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2. Microb Pathog 145:104236. https:\/\/doi.org\/10.1016\/j.micpath.2020.104236","journal-title":"Microb Pathog"},{"key":"3003_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105387","volume":"151","author":"S Ahmad","year":"2020","unstructured":"Ahmad S, Navid A, Farid R, Abbas G, Ahmad F, Zaman N et al (2020) Design of a novel multi epitope-based vaccine for pandemic coronavirus disease (COVID-19) by vaccinomics and probable prevention strategy against avenging zoonotics. Eur J Pharm Sci 151:105387. https:\/\/doi.org\/10.1016\/j.ejps.2020.105387","journal-title":"Eur J Pharm Sci"},{"key":"3003_CR109","doi-asserted-by":"publisher","first-page":"113612","DOI":"10.1016\/j.molliq.2020.113612","volume":"314","author":"S Ismail","year":"2020","unstructured":"Ismail S, Ahmad S, Azam SS (2020) Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine. J Mol Liq 314:113612. https:\/\/doi.org\/10.1016\/j.molliq.2020.113612","journal-title":"J Mol Liq"},{"key":"3003_CR110","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/jmv.25698","volume":"92","author":"V Baruah","year":"2020","unstructured":"Baruah V, Bose S (2020) Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV. J Med Virol 92:495\u2013500. https:\/\/doi.org\/10.1002\/jmv.25698","journal-title":"J Med Virol"},{"key":"3003_CR111","doi-asserted-by":"publisher","first-page":"100338","DOI":"10.1016\/j.imu.2020.100338","volume":"19","author":"A Joshi","year":"2020","unstructured":"Joshi A, Joshi BC, Mannan MA, Kaushik V (2020) Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach. Inf Med Unlocked 19:100338. https:\/\/doi.org\/10.1016\/j.imu.2020.100338","journal-title":"Inf Med Unlocked"},{"key":"3003_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104382","volume":"84","author":"Y Vashi","year":"2020","unstructured":"Vashi Y, Jagrit V, Kumar S (2020) Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: a computational way to predict the immunogens. Infect Genet Evol 84:104382. https:\/\/doi.org\/10.1016\/j.meegid.2020.104382","journal-title":"Infect Genet Evol"},{"key":"3003_CR113","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/jmv.25736","volume":"92","author":"M Bhattacharya","year":"2020","unstructured":"Bhattacharya M, Sharma AR, Patra P, Ghosh P, Sharma G, Patra BC et al (2020) Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): immunoinformatics approach. J Med Virol 92:618\u2013631. https:\/\/doi.org\/10.1002\/jmv.25736","journal-title":"J Med Virol"},{"key":"3003_CR114","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.20.000141","author":"E Ong","year":"2020","unstructured":"Ong E, Wong MU, Huffman A, He Y (2020) COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning. BioRxiv. https:\/\/doi.org\/10.1101\/2020.03.20.000141","journal-title":"BioRxiv"},{"key":"3003_CR115","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.03.962332","author":"Y Feng","year":"2020","unstructured":"Feng Y, Qiu M, Zou S, Li Y, Luo K, Chen R et al (2020) Multi-epitope vaccine design using an immunoinformatics approach for 2019 novel coronavirus in China (SARS-CoV-2). BioRxiv. https:\/\/doi.org\/10.1101\/2020.03.03.962332","journal-title":"BioRxiv"},{"key":"3003_CR116","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.30.016931","author":"KM Campbell","year":"2020","unstructured":"Campbell KM, Steiner G, Wells DK, Ribas A, Kalbasi A (2020) Prediction of SARS-CoV-2 epitopes across 9360 HLA class I alleles. BioRxiv. https:\/\/doi.org\/10.1101\/2020.03.30.016931","journal-title":"BioRxiv"},{"key":"3003_CR117","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.31.017459","author":"R Saha","year":"2020","unstructured":"Saha R, Prasad BVLS (2020) In silico approach for designing of a multi-epitope based vaccine against novel coronavirus (SARS-COV-2). BioRxiv. https:\/\/doi.org\/10.1101\/2020.03.31.017459","journal-title":"BioRxiv"},{"key":"3003_CR118","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.25.965434","author":"L Li","year":"2020","unstructured":"Li L, Sun T, He Y, Li W, Fan Y, Zhang J (2020) Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2. BioRxiv. https:\/\/doi.org\/10.1101\/2020.02.25.965434","journal-title":"BioRxiv"},{"key":"3003_CR119","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.27.967422","author":"A Basu","year":"2020","unstructured":"Basu A, Sarkar A, Maulik U (2020) Strategies for vaccine design for corona virus using Immunoinformatics techniques. BioRxiv. https:\/\/doi.org\/10.1101\/2020.02.27.967422","journal-title":"BioRxiv"},{"key":"3003_CR120","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s10038-020-0771-5","volume":"65","author":"K Kiyotani","year":"2020","unstructured":"Kiyotani K, Toyoshima Y, Nemoto K, Nakamura Y (2020) Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2. J Hum Genet 65:569\u2013575. https:\/\/doi.org\/10.1038\/s10038-020-0771-5","journal-title":"J Hum Genet"},{"key":"3003_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-81749-9","volume":"11","author":"Z Yang","year":"2021","unstructured":"Yang Z, Bogdan P, Nazarian S (2021) An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study. Sci Rep 11:1\u201321. https:\/\/doi.org\/10.1038\/s41598-021-81749-9","journal-title":"Sci Rep"},{"key":"3003_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78758-5","volume":"10","author":"B Malone","year":"2020","unstructured":"Malone B, Simovski B, Molin\u00e9 C, Cheng J, Gheorghe M, Fontenelle H et al (2020) Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs. Sci Rep 10:1\u201314. https:\/\/doi.org\/10.1038\/s41598-020-78758-5","journal-title":"Sci Rep"},{"key":"3003_CR123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008607","volume":"16","author":"S Silva-Arrieta","year":"2020","unstructured":"Silva-Arrieta S, Goulder PJR, Brander C (2020) In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction. PLoS Pathog 16:e1008607. https:\/\/doi.org\/10.1371\/journal.ppat.1008607","journal-title":"PLoS Pathog"},{"key":"3003_CR124","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1745-6150-8-30","volume":"8","author":"SK Dhanda","year":"2013","unstructured":"Dhanda SK, Vir P, Raghava GPS (2013) Designing of interferon-gamma inducing MHC class-II binders. Biol Direct 8:30. https:\/\/doi.org\/10.1186\/1745-6150-8-30","journal-title":"Biol Direct"},{"key":"3003_CR125","doi-asserted-by":"crossref","unstructured":"Prediction of IL4 Inducing Peptides (n.d.) https:\/\/www.hindawi.com\/journals\/jir\/2013\/263952\/. Accessed 25 June 2020","DOI":"10.1155\/2013\/263952"},{"key":"3003_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep42851","volume":"7","author":"G Nagpal","year":"2017","unstructured":"Nagpal G, Usmani SS, Dhanda SK, Kaur H, Singh S, Sharma M et al (2017) Computer-aided designing of immunosuppressive peptides based on IL-10 inducing potential. Sci Rep 7:1\u201310. https:\/\/doi.org\/10.1038\/srep42851","journal-title":"Sci Rep"},{"key":"3003_CR127","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7079356","author":"R Jakhar","year":"2020","unstructured":"Jakhar R, Gakhar SK (2020) An immunoinformatics study to predict epitopes in the envelope protein of SARS-CoV-2. Can J Infect Dis Med Microbiol. https:\/\/doi.org\/10.1155\/2020\/7079356","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"3003_CR128","doi-asserted-by":"publisher","first-page":"104517","DOI":"10.1016\/J.MEEGID.2020.104517","volume":"85","author":"MRN Akhand","year":"2020","unstructured":"Akhand MRN, Azim KF, Hoque SF, Moli MA, Joy BD, Akter H et al (2020) Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine. Infect Genet Evol 85:104517. https:\/\/doi.org\/10.1016\/J.MEEGID.2020.104517","journal-title":"Infect Genet Evol"},{"key":"3003_CR129","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1128\/JVI.01837-20","volume":"95","author":"A Takagi","year":"2021","unstructured":"Takagi A, Matsui M (2021) Identification of HLA-A*02:01-restricted candidate epitopes derived from the nonstructural polyprotein 1a of SARS-CoV-2 that may be natural targets of CD8+ T cell recognition in vivo. J Virol 95:1837\u20131857. https:\/\/doi.org\/10.1128\/JVI.01837-20","journal-title":"J Virol"},{"key":"3003_CR130","doi-asserted-by":"publisher","first-page":"10464","DOI":"10.1128\/JVI.05039-11","volume":"85","author":"H-LJ Oh","year":"2011","unstructured":"Oh H-LJ, Chia A, Chang CXL, Leong HN, Ling KL, Grotenbreg GM et al (2011) Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope. J Virol 85:10464. https:\/\/doi.org\/10.1128\/JVI.05039-11","journal-title":"J Virol"},{"key":"3003_CR131","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/VACCINES9060581\/S1","volume":"9","author":"AF Cuspoca","year":"2021","unstructured":"Cuspoca AF, D\u00edaz LL, Acosta AF, Pe\u00f1aloza MK, M\u00e9ndez YR, Clavijo DC et al (2021) An immunoinformatics approach for sars-cov-2 in latam populations and multi-epitope vaccine candidate directed towards the world\u2019s population. Vaccines 9:581. https:\/\/doi.org\/10.3390\/VACCINES9060581\/S1","journal-title":"Vaccines"},{"key":"3003_CR132","doi-asserted-by":"publisher","DOI":"10.1002\/SLCT.202103903","author":"OA Durojaye","year":"2022","unstructured":"Durojaye OA, Sedzro DM, Idris MO, Yekeen AA, Fadahunsi AA, Alakanse OS (2022) Identification of a potential mRNA-based vaccine candidate against the SARS-CoV-2 spike glycoprotein: a reverse vaccinology approach. ChemistrySelect. https:\/\/doi.org\/10.1002\/SLCT.202103903","journal-title":"ChemistrySelect"},{"key":"3003_CR133","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/J.JTUMED.2022.02.007","volume":"17","author":"RA Febrianti","year":"2022","unstructured":"Febrianti RA, Narulita E (2022) In-silico analysis of recombinant protein vaccines based on the spike protein of Indonesian SARS-CoV-2 through a reverse vaccinology approach. J Taibah Univ Med Sci 17:467. https:\/\/doi.org\/10.1016\/J.JTUMED.2022.02.007","journal-title":"J Taibah Univ Med Sci"},{"key":"3003_CR134","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/S41590-020-0782-6","volume":"21","author":"Y Peng","year":"2020","unstructured":"Peng Y, Mentzer AJ, Liu G, Yao X, Yin Z, Dong D et al (2020) Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat Immunol 21:1336\u20131345. https:\/\/doi.org\/10.1038\/S41590-020-0782-6","journal-title":"Nat Immunol"},{"key":"3003_CR135","doi-asserted-by":"publisher","first-page":"6461","DOI":"10.1126\/sciimmunol.abg6461","volume":"6","author":"B Agerer","year":"2021","unstructured":"Agerer B, Koblischke M, Gudipati V, Monta\u00f1o-Gutierrez LF, Smyth M, Popa A et al (2021) SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses. Sci Immunol 6:6461. https:\/\/doi.org\/10.1126\/sciimmunol.abg6461","journal-title":"Sci Immunol"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-022-03003-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-022-03003-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-022-03003-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T04:31:34Z","timestamp":1676694694000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-022-03003-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":135,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["3003"],"URL":"https:\/\/doi.org\/10.1007\/s00284-022-03003-3","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"assertion":[{"value":"18 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"306"}}